This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/kegg-compound/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/drugbank/
n16http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02245/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02245
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB02245 n16:DB02245
dcterms:title
7-Deazaguanine
adms:identifier
n7:3668976 n8:DB02245 n9:17433 n10:4470573 n13:46508935 n14:C01449 n15:7DG
n3:IUPAC-Name
n4:271B4B44-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4B4A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4B49-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4B46-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4B47-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4B48-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4B42-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4B40-363D-11E5-9242-09173F13E4C5 n4:271B4B43-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4B41-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4B50-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4B51-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4B4B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4B4C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4B4E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4B4D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4B4F-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
7355-55-7
n3:Bioavailability
n4:271B4B56-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4B58-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4B59-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4B55-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4B54-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4B57-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4B45-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4B52-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4B53-363D-11E5-9242-09173F13E4C5